The proteoglycan aggrecan is an important major component of cartilage matr
ix that gives articular cartilage the ability to withstand compression, Inc
reased breakdown of aggrecan is associated with the development of arthriti
s and is considered to be catalyzed by aggrecanases, members of the ADAM-TS
family of metalloproteinases. Four endogenous tissue inhibitors of metallo
proteinases (TIMPs) regulate the activities of functional matrix metallopro
teinases (MMPs), enzymes that degrade most components of connective tissue,
but no endogenous factors responsible for the regulation of aggrecanases h
ave been found. We show here that the N-terminal inhibitory domain of TIMP-
3, a member of the TIMP family that has functional properties distinct from
other TIMPs, is a strong inhibitor of human aggrecanases 1 and 2, with K-i
values in the subnanomolar range. This truncated inhibitor, which lacks th
e C-terminal domain that is responsible for interactions with molecules oth
er than active metalloproteinases, is produced at high yield by bacterial e
xpression and folding from inclusion bodies. This provides a starting point
for developing a biologically available aggrecanase inhibitor suitable for
the treatment of arthritis.